DBI:NYSEDesigner Brands Inc. Analysis
Data as of 2026-06-13 - not real-time
$6.88
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Designer Brands is trading at $6.88, comfortably above its 20‑day SMA ($7.47) but still below the 200‑day SMA ($5.92) and the 52‑week high of $9.17, indicating a modest bullish bias despite a bearish MACD histogram. The stock posted an earnings beat in Q1 2026, yet the full‑year outlook disappointed investors, driving a 9% drop and leaving the RSI at a neutral 44.3. Volume is increasing, but the 30‑day volatility is extremely high at 95%, and beta exceeds 2, underscoring pronounced price swings.
Valuation is mixed: a trailing P/E of 31.3 looks stretched, but a forward P/E of 11.7 and a price‑to‑sales of 0.12 suggest upside potential. The dividend yield of 3.05% is attractive, though a 68% payout ratio combined with a debt‑to‑equity of 431 raises sustainability concerns. Overall, the company sits in a high‑risk consumer‑cyclical space with weak revenue growth (1.4%) and thin profit margins, making the stock a speculative play that hinges on a successful turnaround and debt reduction.
Valuation is mixed: a trailing P/E of 31.3 looks stretched, but a forward P/E of 11.7 and a price‑to‑sales of 0.12 suggest upside potential. The dividend yield of 3.05% is attractive, though a 68% payout ratio combined with a debt‑to‑equity of 431 raises sustainability concerns. Overall, the company sits in a high‑risk consumer‑cyclical space with weak revenue growth (1.4%) and thin profit margins, making the stock a speculative play that hinges on a successful turnaround and debt reduction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Weak full‑year guidance after earnings beat
- Bearish MACD and high short‑term volatility
- Elevated debt load limiting upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward earnings multiple suggests undervaluation
- Attractive dividend yield but high payout ratio
- Continued sector cyclicality risk
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Potential upside from debt reduction and margin improvement
- Low price‑to‑sales and forward P/E indicating value
- Sustained dividend income if cash flow stabilizes
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin0.36%
P/E Ratio31.3
ROE5.61%
ROA2.28%
Debt/Equity431.10
P/B Ratio1.2
Op. Cash Flow$108.2M
Free Cash Flow$75.4M
Technical Analysis
TrendBullish
RSI44.3
Support$5.90
Resistance$9.17
MA 20$7.47
MA 50$7.23
MA 200$5.92
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Target Price$7.75
Upside/Downside12.65%
GradeFair
TypeValue
Dividend Yield3.05%
Risk Assessment
Beta2.17
Volatility95.10%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.